These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 12909286)

  • 1. NAAG synthetase deficiency has only low influence on pathogenesis in a Canavan disease mouse model.
    Becker I; Wang-Eckhardt L; Eckhardt M
    J Inherit Metab Dis; 2024 Mar; 47(2):230-243. PubMed ID: 38011891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astroglial conditional Slc13a3 knockout is therapeutic in murine Canavan leukodystrophy.
    Hull VL; Wang Y; McDonough J; Zhu M; Burns T; Al Ramel N; Dehghani A; Guo F; Pleasure D
    Ann Clin Transl Neurol; 2024 Apr; 11(4):1059-1062. PubMed ID: 38282243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model.
    Guo F; Bannerman P; Mills Ko E; Miers L; Xu J; Burns T; Li S; Freeman E; McDonough JA; Pleasure D
    Ann Neurol; 2015 May; 77(5):884-8. PubMed ID: 25712859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin lesion in the aspartoacylase (Aspa) knockout rat, an animal model for Canavan disease.
    Takeda S; Hoshiai R; Tanaka M; Izawa T; Yamate J; Kuramoto T; Kuwamura M
    Exp Anim; 2024 Jul; 73(3):347-356. PubMed ID: 38538326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human induced pluripotent stem cell line (SDQLCHi064-A) derived from a patient with Canavan disease carrying c.556_559dup GTTC and c.919delA mutations in the ASPA gene.
    Liu N; Ge Y; Yang Y; Zhao F; Lv Y; Li Z; Dong R; Liu Y; Gai Z
    Stem Cell Res; 2024 Apr; 76():103325. PubMed ID: 38309148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redirecting
    Gessler DJ; Li D; Xu H; Su Q; Sanmiguel J; Tuncer S; Moore C; King J; Matalon R; Gao G
    JCI Insight; 2017 Feb; 2(3):e90807. PubMed ID: 28194442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canavan's spongiform leukodystrophy (Aspartoacylase deficiency) with emphasis on sonographic features in infancy: description of a case report and review of the literature.
    Rossler L; Lemburg S; Weitkämper A; Thiels C; Hoffjan S; Nguyen HP; Lücke T; Heyer CM
    J Ultrasound; 2023 Dec; 26(4):757-764. PubMed ID: 35187608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rAAV Gene Therapy in a Canavan's Disease Mouse Model Reveals Immune Impairments and an Extended Pathology Beyond the Central Nervous System.
    Ahmed SS; Schattgen SA; Frakes AE; Sikoglu EM; Su Q; Li J; Hampton TG; Denninger AR; Kirschner DA; Kaspar B; Matalon R; Gao G
    Mol Ther; 2016 Jun; 24(6):1030-1041. PubMed ID: 27039844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of Canavan disease: 23 new cases and comparison with patients from literature.
    Bley A; Denecke J; Kohlschütter A; Schön G; Hischke S; Guder P; Bierhals T; Lau H; Hempel M; Eichler FS
    Orphanet J Rare Dis; 2021 May; 16(1):227. PubMed ID: 34011350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous Paternally Inherited
    Yalcintepe S; Maras T; Kizilyar I; Sezginer Guler H; Zhuri D; Atli E; Ozen Y; Gurkan H
    Mol Syndromol; 2024 Aug; 15(4):284-288. PubMed ID: 39119446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The full spectrum of MRI findings in 18 patients with Canavan disease: new insights into the areas of selective susceptibility.
    Rahimian E; D'Arco F; Sudhakar S; Tahsini MR; Azin N; Morovvati M; Karimzadeh P; Farahvash MA
    Neuroradiology; 2024 Oct; 66(10):1829-1835. PubMed ID: 38880823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease.
    Grønbæk-Thygesen M; Hartmann-Petersen R
    Cell Biosci; 2024 Apr; 14(1):45. PubMed ID: 38582917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional changes in the rat brain induced by repetitive transcranial magnetic stimulation.
    Weiler M; Stieger KC; Shroff K; Klein JP; Wood WH; Zhang Y; Chandrasekaran P; Lehrmann E; Camandola S; Long JM; Mattson MP; Becker KG; Rapp PR
    Front Hum Neurosci; 2023; 17():1215291. PubMed ID: 38021223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of experimental traumatic brain injury modulates changes in concentrations of cerebral free amino acids.
    Amorini AM; Lazzarino G; Di Pietro V; Signoretti S; Lazzarino G; Belli A; Tavazzi B
    J Cell Mol Med; 2017 Mar; 21(3):530-542. PubMed ID: 27696676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of glutamate transporter, GABRA6, serine proteinase inhibitor 2 and low levels of glutamate and GABA in the brain of knock-out mouse for Canavan disease.
    Surendran S; Rady PL; Michals-Matalon K; Quast MJ; Rassin DK; Campbell GA; Ezell EL; Wei J; Tyring SK; Szucs S; Matalon R
    Brain Res Bull; 2003 Aug; 61(4):427-35. PubMed ID: 12909286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canavan disease: a monogenic trait with complex genomic interaction.
    Surendran S; Michals-Matalon K; Quast MJ; Tyring SK; Wei J; Ezell EL; Matalon R
    Mol Genet Metab; 2003; 80(1-2):74-80. PubMed ID: 14567959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canavan disease: studies on the knockout mouse.
    Matalon R; Michals-Matalon K; Surendran S; Tyring SK
    Adv Exp Med Biol; 2006; 576():77-93; discussion 361-3. PubMed ID: 16802706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental retardation and hypotonia seen in the knock out mouse for Canavan disease is not due to succinate semialdehyde dehydrogenase deficiency.
    Surendran S; Ezell EL; Quast MJ; Wei J; Tyring SK; Michals-Matalon K; Matalon R
    Neurosci Lett; 2004 Mar; 358(1):29-32. PubMed ID: 15016427
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.